Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M67.4Revenue $M1.3Net Margin (%)-8,277.6Z-Score-5.5
Enterprise Value $M-4.1EPS $-2.1Operating Margin %-8,035.9F-Score3
P/E(ttm))0Cash Flow Per Share $0.8Pre-tax Margin (%)-8,277.6Higher ROA y-yY
Price/Book1.010-y EBITDA Growth Rate %0Quick Ratio3.2Cash flow > EarningsN
Price/Sales4.15-y EBITDA Growth Rate %0Current Ratio3.2Lower Leverage y-yY
Price/Cash Flow7.1y-y EBITDA Growth Rate %0ROA % (ttm)-73.1Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-153.0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M52.3ROI % (ttm)-74.6Gross Margin Increase y-yN

Gurus Latest Trades with AVEO

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AVEOSeth Klarman 2013-06-30 Reduce-0.26%$2.34 - $8.27
($4.27)
$ 1.29-70%Reduce -21.9%3,829,350
AVEOGeorge Soros 2011-12-31 Sold Out -0.0031%$14.53 - $17.35
($8.42)
$ 1.29-85%Sold Out0
AVEOSeth Klarman 2011-09-30 Add0.29%$15.12 - $20.77
($17.66)
$ 1.29-93%Add 12.79%5,000,000
AVEOGeorge Soros 2011-09-30 Reduce-0.04%$15.12 - $20.77
($17.66)
$ 1.29-93%Reduce -92.8%11,600
AVEOSeth Klarman 2011-06-30 Add0.78%$13.06 - $20.66
($16.79)
$ 1.29-92%Add 25.76%4,433,010
AVEOGeorge Soros 2011-06-30 Buy 0.05%$13.06 - $20.66
($16.79)
$ 1.29-92%New holding, 161000 sh.161,000
AVEOSeth Klarman 2011-03-31 Add1.15%$13.15 - $15.02
($14.21)
$ 1.29-91%Add 76.25%3,525,000
AVEOSeth Klarman 2010-12-31 Buy 1.68%$13.84 - $17.41
($15.14)
$ 1.29-92%New holding, 2000000 sh.2,000,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AVEO is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
AVEO Seth Klarman 2014-03-313,829,3507.330.14
Premium Most recent portfolio changes are included for Premium Members only!


AVEO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Vittiglio JosephSVP, General Counsel 2014-01-30Sell5,430$1.64-21.34view
Gyuris JenoSVP, Chief Scientific Officer 2014-01-30Sell5,430$1.64-21.34view
Slichenmyer WilliamChief Medical Officer 2014-01-30Sell5,430$1.64-21.34view
BAILEY MICHAEL PChief Business Officer 2014-01-30Sell5,430$1.64-21.34view
Johnston David BrannonCFO 2013-03-14Sell1,061$7.34-82.43view
TERMEER HENRI ADirector 2013-03-07Buy55,499$6.73-80.83view
YOUNG ROBERT CDirector 2013-02-19Buy990$6.6-80.45view
KUCHERLAPATI RAJU SDirector 2012-12-13Buy15,000$6.74-80.86view
HA NGOC TUANCEO 2012-12-13Buy75,000$6.65-80.6view
TERMEER HENRI ADirector 2012-12-13Buy44,501$6.6-80.45view

Press Releases about AVEO :

    Quarterly/Annual Reports about AVEO:

    News about AVEO:

    Articles On GuruFocus.com
    Wild Card Wonders, Shopping for 52-Week Lows Sep 28 2013 
    Sleepy Sector Wakes Up - Billionaires Hold Biotechs in 52-week Low Sep 03 2013 
    comment on AVEO Mar 15 2013 
    comment on AVEO Mar 15 2013 
    Weekly CEO Buys Highlight: AVEO, ZAZA, TUES, TUES, FRAN, AKVA Dec 16 2012 
    Seth Klarman’s Baupost Group Buys Microsoft Corp., BP, Allied Nevada Gold, Sells Audiovox Corp. Aug 12 2011 
    Seth Klarman’s Baupost Group Q1 Portfolio Update; Buys ANV, SCMR, PDLI, AVEO May 14 2011 
    AVEO Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 11 2011 
    Two Picks from Seth Klarman: PDLI, AVEO Feb 22 2011 
    Hedge Fund Baupost Group buys PDLI, AVEO, ALR, Sells LSTZA, UFS, SLRC, EXXI Feb 11 2011 

    More From Other Websites
    Framing Up Capital Efficiency In Early Stage Biotech Jul 17 2014
    AVEO Pharmaceuticals (AVEO) Jumps: Stock Rises 6.4% Jul 01 2014
    Can the Uptrend Continue for AVEO Pharmaceuticals (AVEO)? Jun 26 2014
    AVEO PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission... Jun 23 2014
    AVEO Pharmaceuticals (AVEO) Catches Eye: Stock Up 11.4% Jun 18 2014
    $5 Or Less: 3 Small, Speculative Biotechs On The Move Jun 17 2014
    Five Biotech Stocks With Big Potential And Billionaire Believers Jun 16 2014
    AVEO PHARMACEUTICALS INC Files SEC form 8-K/A, Costs Associated with Exit or Disposal Activities Jun 13 2014
    AVEO Pharmaceuticals, Inc. (AVEO) in Focus: Stock Rises 7.8% Jun 10 2014
    AVEO Oncology Announces Presentation of AV-203 Phase 1 Results at 2014 American Society of Clinical... May 31 2014
    AVEO Oncology to Present at the Jefferies Global Healthcare Conference May 28 2014
    PTC Therapeutics Up on Positive CHMP Opinion May 27 2014
    Sarepta to Acquire Manufacturing Facility May 23 2014
    AVEO PHARMACEUTICALS INC Financials May 14 2014
    Threshold Pharmaceuticals Presents A Robust Risk/Reward As A Speculative Small-Cap Cancer Investment May 09 2014
    Narrower-than-Expected Loss at AVEO May 08 2014
    AVEO Oncology Reports First Quarter 2014 Financial Results May 07 2014
    AVEO PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report May 07 2014
    Q1 2014 AVEO Oncology Earnings Release - After Market Close May 07 2014
    AVEO Oncology to Report First Quarter 2014 Financial Results on May 7, 2014 May 05 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide